Skip to content

Journal of Mass Spectrometry

ISSN 1076-5174

2 papers in the library · 171 citations · publishing 2003-2016

Papers

Sort Most recent Most cited

Mass spectrometric properties of N‐(2‐methoxybenzyl)‐2‐(2,4,6‐trimethoxyphenyl)ethanamine (2,4,6‐TMPEA‐NBOMe), a new representative of designer drugs of NBOMe series and derivatives thereof

Journal of Mass Spectrometry October 1, 2016 Vadim A Shevyrin, Olga V. Kupriyanova, Albert T. Lebedev et al.

Emergence of new psychoactive substances, hallucinogenic phenethylamines in particular, in illicit market is a serious threat to human health in global scale. We have detected and identified N‐(2‐methoxybenzyl)‐2‐(2,4,6‐trimethoxyphenyl)ethanamine (2,4,6‐TMPEA‐NBOMe), a new compound in NBOMe series. Identification was achieved by means of gas chromatography/mass spectrometry (GC/MS), including...

Screening for and validated quantification of amphetamines and of amphetamine‐ and piperazine‐derived designer drugs in human blood plasma by gas chromatography/mass spectrometry

Journal of Mass Spectrometry June 1, 2003 Frank T. Peters, Simone Schaëfer, Roland F. Staack et al. 171 citations

Abstract The classical stimulants amphetamine, methamphetamine, ethylamphetamine and the amphetamine‐derived designer drugs MDA, MDMA (‘ecstasy’), MDEA, BDB and MBDB have been widely abused for a relatively long time. In recent years, a number of newer designer drugs have entered the illicit drug market. 4‐Methylthioamphetamine (MTA), p ‐methoxyamphetamine (PMA) and p ‐methoxymethamphetamine...